NCT06313853 · RECRUITING

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

This trial is testing a communication coaching program called COACH-Cog, designed to help older adults who have both dementia and cancer make decisions about their cancer treatment. Coaches work with patients and their care partners to better support the patient's wishes and goals during oncology appointments. This is a Phase NA pilot randomized trial — an early-stage test of whether the approach works well enough to study further.

Eligibility criteria

PATIENTS:
Patient Inclusion Criteria:
1. Be age 65 or older
2. Have a clinical diagnosis of Alzheimer's disease or related dementia (ADRD [Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown subtype])
3. Have a clinical diagnosis of cancer (any type or stage)
4. Anticipate a potential decision about cancer-related management, as confirmed by the patient's primary medical oncology clinician.
5. Have a care partner willing and able to participate in the study
6. Are able to read and understand English. The communication coaching session will be delivered in English, thus necessitating this requirement.
7. Be able to provide informed consent (as measured by UBACC) or have a Legally Authorized Representative to provide informed consent
Patient Exclusion Criteria:
Patient exclusion criteria: None
CARE PARTNER:
Care partner inclusion criteria:
1. Age 18 or over
2. Able to read and understand spoken English
3. Able to provide informed consent
Care partner exclusion criteria:
None
ONCOLOGY CLINICIAN:
Oncology clinician inclusion criteria:
1. Oncology clinicians affiliated with the Wilmot Cancer Institute
2. Do not intend to move or retire within the next 2 years.
Oncology clinician exclusion criteria:
None

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-03-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials